江汉大学学报(自然科学版) ›› 2020, Vol. 48 ›› Issue (2): 41-47.doi: 10.16389/j.cnki.cn42-1737/n.2020.02.007

• 医学 • 上一篇    下一篇

阿片类药物联用抗抑郁药治疗晚期癌痛伴抑郁的研究进展

曾媛1,孙建海*2   

  1. 1. 江汉大学 医学院,湖北 武汉 430056;2. 湖北省第三人民医院 肿瘤科,湖北 武汉 430033
  • 发布日期:2020-04-22
  • 通讯作者: 孙建海
  • 作者简介:曾媛(1994— ),女,硕士生,研究方向:肿瘤学癌痛。

Progress in Diagnosis and Treatment on Pain with Depression in Advanced Cancer

ZENG Yuan1,SUN Jianhai*2   

  1. 1. School of Medicine,Jianghan University,Wuhan 430056,Hubei,China;2. Oncology Department,The Third People′s Hospital of Hubei Province,Wuhan 430033,Hubei,China
  • Published:2020-04-22
  • Contact: SUN Jianhai

摘要: 晚期癌痛多为中重度疼痛,发生率较高,是导致恶性肿瘤患者产生抑郁的重要原因之一,而抑郁可能使癌痛难以控制而促进肿瘤进展。近年来国内外报道的晚期癌痛伴抑郁的治疗主要为阿片类药物联合抗抑郁药,就晚期癌痛伴抑郁的诊断、评估及治疗药物的进展进行综述并总结目前治疗手段的不足、最佳评估量表和未来的研究方向。

关键词: 晚期癌痛, 抑郁, 评估, 阿片类药物, 抗抑郁药

Abstract: Advanced cancer pain is mostly moderate to severe pain, and the incidence is high, which is one of the important causes of depression in patients with malignant tumors. Depression may make cancer pain difficult to control and promote tumor progress. In recent years, the reports of treatment on pain with depression in advanced cancer at home and abroad were mainly opioid combined with antidepressant. This article reviewed the diagnosis, evaluation and progress of treatment on pain with depression in advanced cancer, also summarized the insufficiency of current treatment methods, assessment scale and future research directions.

Key words: advanced cancer pain, depression, assessment, opioid, antidepressants

中图分类号: